Auckland, New Zealand

Anthony Phillips

This inventor holds 1 USPTO granted patent and 5 published patent applications and 1 EPO patent. Top assignees: Auckland Uniservices Limited, Coda Therapeutics, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anthony Phillips. Retrieved from https://idiyas.com/inventor/anthony-phillips-vzxjbr4c

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Anthony Phillips - Innovator in Pharmaceutical Formulations

Introduction

Anthony Phillips is an inventor based in Auckland, New Zealand. He has made significant contributions to the field of pharmaceutical formulations. Although he currently holds no granted patents, his work is noteworthy for its potential impact on medical treatments.

Latest Patent Applications

Anthony Phillips has filed several patent applications that showcase his innovative ideas. One of his latest applications is for "Lymph-Targeting Formulations." This invention relates to pharmaceutical formulations comprising a lipase inhibitor and long-chain fatty acids. The formulation enables the lipase inhibitor to be delivered to the intestinal lymph, making it useful in the treatment or prevention of diseases and conditions mediated by pancreatic lipase, such as acute pancreatitis and associated syndromes. Another application is for "Channel Modulators." This invention involves compositions and articles of manufacture comprising connexin modulators, pannexin modulators, gap junction modulators, hemichannel modulators, and pannexin channel modulators. These inventions aim to treat ocular and other disorders.

Conclusion

Anthony Phillips is an innovative inventor whose work in pharmaceutical formulations holds promise for future medical advancements. His latest patent applications reflect his commitment to addressing significant health challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…